Company Filing History:
Years Active: 2012-2017
Title: Drazen Raucher: Innovator in Cancer and Neurodegenerative Disease Research
Introduction
Drazen Raucher is a prominent inventor based in Madison, MS (US), known for his significant contributions to the fields of cancer treatment and neurodegenerative disease research. With a total of 4 patents, Raucher has developed innovative solutions aimed at improving therapeutic outcomes for patients.
Latest Patents
Raucher's latest patents include groundbreaking work on the inhibition of metastasis by cell penetrating peptides. This patent describes a compound that combines a cell penetrating peptide (CPP) and elastin-like polypeptide (ELP), which is useful for inhibiting the proliferation of cancer cells. Another notable patent focuses on the composition and methods for targeted delivery of therapeutic compounds to the brain or spinal cord. This invention includes a therapeutic compound for treating neurodegenerative diseases, a cell penetrating peptide (CPP), and a thermal targeting polypeptide (TTP).
Career Highlights
Throughout his career, Drazen Raucher has worked with esteemed institutions such as the University of Mississippi. His research has been pivotal in advancing the understanding and treatment of complex medical conditions.
Collaborations
Raucher has collaborated with notable professionals in his field, including Gene L. Bidwell, III and Waldemar Priebe. These collaborations have further enriched his research and contributed to the development of his innovative patents.
Conclusion
Drazen Raucher's work exemplifies the impact of innovation in medical research, particularly in the areas of cancer and neurodegenerative diseases. His patents reflect a commitment to improving patient care through scientific advancement.